BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 12682293)

  • 1. Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins.
    Sudhakar A; Sugimoto H; Yang C; Lively J; Zeisberg M; Kalluri R
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4766-71. PubMed ID: 12682293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two RGD-independent alpha vbeta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties.
    Maeshima Y; Colorado PC; Kalluri R
    J Biol Chem; 2000 Aug; 275(31):23745-50. PubMed ID: 10837460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular matrix-derived peptide binds to alpha(v)beta(3) integrin and inhibits angiogenesis.
    Maeshima Y; Yerramalla UL; Dhanabal M; Holthaus KA; Barbashov S; Kharbanda S; Reimer C; Manfredi M; Dickerson WM; Kalluri R
    J Biol Chem; 2001 Aug; 276(34):31959-68. PubMed ID: 11399763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumstatin, an endothelial cell-specific inhibitor of protein synthesis.
    Maeshima Y; Sudhakar A; Lively JC; Ueki K; Kharbanda S; Kahn CR; Sonenberg N; Hynes RO; Kalluri R
    Science; 2002 Jan; 295(5552):140-3. PubMed ID: 11778052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of endostatin with integrins implicated in angiogenesis.
    Rehn M; Veikkola T; Kukk-Valdre E; Nakamura H; Ilmonen M; Lombardo C; Pihlajaniemi T; Alitalo K; Vuori K
    Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1024-9. PubMed ID: 11158588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PTEN/Akt pathway dictates the direct alphaVbeta3-dependent growth-inhibitory action of an active fragment of tumstatin in glioma cells in vitro and in vivo.
    Kawaguchi T; Yamashita Y; Kanamori M; Endersby R; Bankiewicz KS; Baker SJ; Bergers G; Pieper RO
    Cancer Res; 2006 Dec; 66(23):11331-40. PubMed ID: 17145879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha(v)beta3 and alpha(v)beta5 integrins bind both the proximal RGD site and non-RGD motifs within noncollagenous (NC1) domain of the alpha3 chain of type IV collagen: implication for the mechanism of endothelia cell adhesion.
    Pedchenko V; Zent R; Hudson BG
    J Biol Chem; 2004 Jan; 279(4):2772-80. PubMed ID: 14610079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The alpha 3(IV)185-206 peptide from noncollagenous domain 1 of type IV collagen interacts with a novel binding site on the beta 3 subunit of integrin alpha Vbeta 3 and stimulates focal adhesion kinase and phosphatidylinositol 3-kinase phosphorylation.
    Pasco S; Monboisse JC; Kieffer N
    J Biol Chem; 2000 Oct; 275(42):32999-3007. PubMed ID: 10934203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endostatin associates with integrin alpha5beta1 and caveolin-1, and activates Src via a tyrosyl phosphatase-dependent pathway in human endothelial cells.
    Wickström SA; Alitalo K; Keski-Oja J
    Cancer Res; 2002 Oct; 62(19):5580-9. PubMed ID: 12359771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha1beta1 integrin.
    Sudhakar A; Nyberg P; Keshamouni VG; Mannam AP; Li J; Sugimoto H; Cosgrove D; Kalluri R
    J Clin Invest; 2005 Oct; 115(10):2801-10. PubMed ID: 16151532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endostatin inhibits adhesion of endothelial cells to collagen I via alpha(2)beta(1) integrin, a possible cause of prevention of chondrosarcoma growth.
    Furumatsu T; Yamaguchi N; Nishida K; Kawai A; Kunisada T; Namba M; Inoue H; Ninomiya Y
    J Biochem; 2002 Apr; 131(4):619-26. PubMed ID: 11927001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity.
    Eikesdal HP; Sugimoto H; Birrane G; Maeshima Y; Cooke VG; Kieran M; Kalluri R
    Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15040-5. PubMed ID: 18818312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of COX-2 mediated signaling by alpha3 type IV noncollagenous domain in tumor angiogenesis.
    Boosani CS; Mannam AP; Cosgrove D; Silva R; Hodivala-Dilke KM; Keshamouni VG; Sudhakar A
    Blood; 2007 Aug; 110(4):1168-77. PubMed ID: 17426256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin.
    Hamano Y; Zeisberg M; Sugimoto H; Lively JC; Maeshima Y; Yang C; Hynes RO; Werb Z; Sudhakar A; Kalluri R
    Cancer Cell; 2003 Jun; 3(6):589-601. PubMed ID: 12842087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of tumor angiogenesis by tumstatin: insights into signaling mechanisms and implications in cancer regression.
    Sudhakar A; Boosani CS
    Pharm Res; 2008 Dec; 25(12):2731-9. PubMed ID: 18551250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel RGD antagonist that targets both alphavbeta3 and alpha5beta1 induces apoptosis of angiogenic endothelial cells on type I collagen.
    Meerovitch K; Bergeron F; Leblond L; Grouix B; Poirier C; Bubenik M; Chan L; Gourdeau H; Bowlin T; Attardo G
    Vascul Pharmacol; 2003 Feb; 40(2):77-89. PubMed ID: 12646396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity.
    Sasaki T; Larsson H; Tisi D; Claesson-Welsh L; Hohenester E; Timpl R
    J Mol Biol; 2000 Sep; 301(5):1179-90. PubMed ID: 10966814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors.
    Sund M; Hamano Y; Sugimoto H; Sudhakar A; Soubasakos M; Yerramalla U; Benjamin LE; Lawler J; Kieran M; Shah A; Kalluri R
    Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2934-9. PubMed ID: 15710885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis.
    Dixelius J; Larsson H; Sasaki T; Holmqvist K; Lu L; Engström A; Timpl R; Welsh M; Claesson-Welsh L
    Blood; 2000 Jun; 95(11):3403-11. PubMed ID: 10828022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin.
    Maeshima Y; Manfredi M; Reimer C; Holthaus KA; Hopfer H; Chandamuri BR; Kharbanda S; Kalluri R
    J Biol Chem; 2001 May; 276(18):15240-8. PubMed ID: 11278365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.